MADAUDO, Cristina
 Distribuzione geografica
Continente #
EU - Europa 1.818
NA - Nord America 1.684
AS - Asia 1.506
Continente sconosciuto - Info sul continente non disponibili 389
SA - Sud America 288
AF - Africa 49
OC - Oceania 7
Totale 5.741
Nazione #
US - Stati Uniti d'America 1.580
IT - Italia 702
RU - Federazione Russa 572
SG - Singapore 504
CN - Cina 296
BR - Brasile 218
BD - Bangladesh 196
VN - Vietnam 190
PL - Polonia 117
HK - Hong Kong 99
FI - Finlandia 90
DE - Germania 88
FR - Francia 68
JP - Giappone 62
GB - Regno Unito 50
NL - Olanda 46
CA - Canada 39
AR - Argentina 35
IN - India 35
MX - Messico 24
IQ - Iraq 19
TR - Turchia 16
SE - Svezia 14
ZA - Sudafrica 14
PK - Pakistan 12
AT - Austria 11
ES - Italia 11
PH - Filippine 9
EC - Ecuador 8
ID - Indonesia 8
AL - Albania 7
CR - Costa Rica 7
CU - Cuba 7
IE - Irlanda 7
KR - Corea 7
TN - Tunisia 7
UZ - Uzbekistan 7
DZ - Algeria 6
HN - Honduras 6
UA - Ucraina 6
AE - Emirati Arabi Uniti 5
AU - Australia 5
AZ - Azerbaigian 5
BE - Belgio 5
CL - Cile 5
CO - Colombia 5
MY - Malesia 5
PE - Perù 5
VE - Venezuela 5
GR - Grecia 4
GT - Guatemala 4
JM - Giamaica 4
MA - Marocco 4
PR - Porto Rico 4
RO - Romania 4
AO - Angola 3
BG - Bulgaria 3
BO - Bolivia 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
EG - Egitto 3
KZ - Kazakistan 3
TW - Taiwan 3
BB - Barbados 2
CZ - Repubblica Ceca 2
IL - Israele 2
IR - Iran 2
KE - Kenya 2
KH - Cambogia 2
KW - Kuwait 2
LB - Libano 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PY - Paraguay 2
SA - Arabia Saudita 2
UY - Uruguay 2
YE - Yemen 2
AM - Armenia 1
BM - Bermuda 1
CH - Svizzera 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MG - Madagascar 1
MM - Myanmar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
QA - Qatar 1
SB - Salomone, isole 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 5.345
Città #
Singapore 316
San Jose 300
Ashburn 283
Council Bluffs 106
Zgierz 99
Hong Kong 97
Moscow 86
Milan 82
Los Angeles 79
New York 78
Palermo 77
Dallas 67
Rome 67
Helsinki 61
Ho Chi Minh City 61
Tokyo 59
Hanoi 47
Hefei 44
Beijing 42
Lauterbourg 37
Santa Clara 37
Buffalo 34
Boardman 26
Lappeenranta 25
Chicago 20
Frankfurt am Main 19
Munich 18
Naples 18
São Paulo 18
The Dalles 18
Bari 17
Chandler 17
Da Nang 16
London 16
Amsterdam 15
Atlanta 14
Bologna 14
Brooklyn 13
Nuremberg 13
Montreal 12
Orem 12
Shanghai 12
Warsaw 12
Denver 10
Mexico City 10
Seattle 10
Toronto 10
Catania 9
Hải Dương 9
Buenos Aires 8
Charlotte 8
Houston 8
Ludwigshafen am Rhein 8
Phoenix 8
Venice 8
Chennai 7
Curitiba 7
Dublin 7
Florence 7
Havana 7
Parma 7
Stockholm 7
Tirana 7
Belo Horizonte 6
Columbus 6
Goiânia 6
Guangzhou 6
Haiphong 6
Padua 6
Redondo Beach 6
Vienna 6
Cambridge 5
Falkenstein 5
Greensboro 5
Guayaquil 5
Hillsboro 5
Johannesburg 5
Monza 5
Poplar 5
Querétaro 5
Salt Lake City 5
San Francisco 5
San José 5
Shenzhen 5
Tashkent 5
Baku 4
Boston 4
Brussels 4
Cape Town 4
Duque de Caxias 4
Erbil 4
Fairfield 4
Guatemala City 4
Lima 4
Manaus 4
Manchester 4
Paris 4
Pune 4
San Diego 4
Tampa 4
Totale 2.844
Nome #
The new HFA/ICOS risk assessment tool to identify patients with chronic myeloid leukaemia at high risk of cardiotoxicity 288
ANOCA, INOCA, MINOCA: The New Frontier of Coronary Syndromes. 271
A possible easy way to predict response to cardiac resynchronization therapy: The role of QRS Index 201
Assessment of cancer therapy-related cardiac dysfunction in breast cancer women using a new speckle tracking echocardiography index: The GAVS 177
Artificial intelligence in cardiology: a peek at the future and the role of ChatGPT in cardiology practice 173
Exploring the role of Glial Fibrillary Acid Protein (GFAP) in Acute coronary syndrome 161
Arterial Stiffness: Effects of Anticancer Drugs Used for Breast Cancer Women 152
Left Ventricular Deformation and Myocardial Work Parameters in Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran: A Single-Center Study 140
Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different? 138
Role of Lipoprotein Ratios and Remnant Cholesterol in Patients with Myocardial Infarction with Non-Obstructive Coronary Arteries (MINOCA) 131
Procedural Impact of Advanced Calcific Plaque Modification Devices Within Percutaneous Revascularization of Chronic Total Occlusions. 129
Longitudinal Strain Analysis and Correlation with TIMI Frame Count in Patients with Ischemia with No Obstructive Coronary Artery (INOCA) and Microvascular Angina (MVA) 126
Impact of Metabolic Syndrome on Coronary Microvascular Dysfunction: A Single Center Experience 125
Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices 122
Management of a patient with multiple device replacements and extractions: When the leadless pacemaker is a viable solution 120
Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis 119
Contractile Reserve in Heart Failure with Preserved Ejection Fraction 119
What happened to the left ventricular non-compaction cardiomyopathy? to be or not to be: This is the question 118
The added value of the HFA/ICOS score in the prediction of chemotherapy-related cardiac dysfunction in breast cancer 116
Coronary Revascularization in Patients with Hemophilia and Acute Coronary Syndrome: Case Report and Brief Literature Review 114
Right ventricle involvement in patients with breast cancer treated with chemotherapy 114
Classification, Diagnosis, and Treatment of Coronary Microvascular Dysfunction 113
Dysfunctional High-Density Lipoprotein Cholesterol and Coronary Artery Disease: A Narrative Review 106
The Impact of Triglyceride-Glucose (TyG) Index on Future Cardio and Cerebrovascular Events in Patients with Acute Coronary Syndrome, During 3 Years of Follow-Up 100
Higher Incidence of Cancer Therapy-Related Cardiac Dysfunction in the COVID-19 Era: A Single Cardio-Oncology Center Experience 95
Optimal Timing of Angiography-Guided Complete Revascularization of Non-Culprit Lesions in STEMI Patients with Multivessel Disease 93
Gastrointestinal Bleeding During Long-Term Left Ventricular Assist Device Support: External Validation of UTAH Bleeding Risk Score 92
Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology) 90
Cancer survivors and cardiovascular diseases: from preventive strategies to treatment 88
The ANOCA/INOCA Dilemma Considering the 2024 ESC Guidelines on Chronic Coronary Syndromes 88
Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy 86
Effects of sodium-glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis 84
The Genetic Puzzle of the Stress-Induced Cardiomyopathy (Takotsubo Syndrome): State of Art and Future Perspectives 83
Prognosis of myocarditis stratified by initial clinical presentation: Does "intermediate" risk still play a role? 79
Blood Cell Subtype patterns in Takotsubo Syndrome and acute coronary syndrome: analysis from the GEIST registry 77
SGLT2 inhibitor therapy in patients with advanced heart failure and reduced ejection fraction 75
Improving cardiovascular health today to prevent heart failure tomorrow: the importance of a holistic approach 75
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality? 72
Multimodality Assessment for Durable Mechanical Circulatory Support Implantation 70
Neutrophil‐to‐lymphocyte ratio for risk stratification in acute myocarditis across the left ventricular ejection fraction spectrum 69
Advancing Cardiovascular Diagnostics: The Expanding Role of CMR in Heart Failure and Cardiomyopathies 68
Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions 67
Tricuspid transcatheter edge-to-edge repair for severe symptomatic tricuspid regurgitation: a systematic review and meta-analysis 65
Denosumab for cancer-related bone loss 62
Discovering Inflammation in Atherosclerosis: Insights from Pathogenic Pathways to Clinical Practice 61
Tighter is better: Can a simple and cost‐free parameter predict response to cardiac synchronization therapy? 57
Right Ventricular Function and Ventricular–Arterial Coupling in HFpEF and HFmrEF Treated With SGLT2 Inhibitors: A Multicenter Echocardiographic Analysis From the DISCOVER-SGLT2i Registry 56
Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers 54
The Role of Inflammation in Takotsubo Syndrome: From Pathogenic Pathways To Imaging Insights and Therapeutic Perspectives 47
2017 Marathon of Rome: Anthropometry and Sport Profile in 350 Runners and Association With Achilles and Patellar Tendinopathy 42
Corrigendum to:“The changing landscape of Heart Failure: translating management into the modern era”(European Journal of Internal Medicine, (2025), (106633), (S0953620525005102), 10.1016/j.ejim.2025.106633) 38
Current and future landscape of heart failure management: understanding the present, unraveling the future 37
Are We Ready to Monitor the Atrium? From Ventricular-Centric to Chamber-Integrated Cardiotoxicity Surveillance: The Emerging Role of Left Atrial Strain 37
Revascularization of patients with chronic total occlusion and left ventricular systolic dysfunction 35
The Quantitative Haemodynamic Effect of Levosimendan, Dobutamine and Milrinone in Heart Failure Patients: a Meta-Analysis 32
QRS Index as a Predictor of Response to Cardiac Resynchronization Therapy: A Systematic Review and Meta-Analysis 29
Interleukin-1 Blockade in Myocardial Infarction and Its Efficacy in Patients With Complex Coronary Artery Disease: Another Brick in the Wall 27
Burnout Among Italian Medical Doctors: A Cross-Sectional Study on Emotional Exhaustion, Depersonalization, and Gratification Post-COVID-19 25
The changing landscape of heart failure: translating management into the modern era 22
Tirzepatide and the Cardiovascular Continuum: Metabolic, Cardiorenal and Heart Failure Evidence 21
Impact of Insulin Resistance and Preclinical Atherosclerosis Parameters in Long-Term Prediction of Cardiovascular Events: A Seven-Year Prospective Study 20
Management of Bleeding Disorder During Dual Antiplatelet Therapy 11
Patient profiles and outcomes of chronic total occlusion percutaneous revascularisation in middle- and high-income regions a cross-sectional study from the European Registry of Chronic Total Occlusions (ERCTO) 11
Myocarditis Prognostic Score: A New Risk Assessment Tool 10
Percutaneous coronary intervention or conservative therapy for chronic total coronary occlusions (CTOs)? Evidence from the ISCHEMIA trial 10
First quinquennium completed: highlights from EHJ Open 2025 8
Totale 5.741
Categoria #
all - tutte 17.932
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.932


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202230 0 0 0 0 0 0 0 5 3 9 6 7
2022/2023145 3 10 1 5 6 11 14 43 22 4 6 20
2023/2024195 3 16 20 28 10 28 14 4 2 7 37 26
2024/2025849 17 16 43 81 29 29 133 74 65 93 114 155
2025/20264.305 175 181 275 442 449 499 514 469 384 247 337 333
2026/2027217 217 0 0 0 0 0 0 0 0 0 0 0
Totale 5.741